New QuikClot(r) NoseBleed(tm) brand is a gauze packing that uses a nanotechnology that rapidly stops bleeding. This product is a safe, simple and effective treatment that can help consumers avoid one of the 515,000 emergency room visits each year due to nosebleeds. It is available online at www.quikclot.com.

Wallingford, Conn. (PRWEB) August 25, 2008 -- Every year in the United States, there are close to 400 million nosebleeds. While many nosebleeds are minor, about 515,000 result in visits to hospital emergency departments -- stressful, time consuming and expensive incidents. Nosebleeds occur most frequently in two age groups, children two to ten years old, and seniors. Z-Medica Corp is now making a difference for mothers and caregivers to these loved ones with QuikClot® NoseBleed™ brand, a safe and economical new way to stop nasal bleeding.

QuikClot® NoseBleed™ brand, a gauze packing impregnated with a specially formulated substance that activates factors in blood to promote rapid blood coagulation, comes in an easy to apply and easy to remove format. It has been cleared by the FDA for over-the-counter use by anyone who can follow simple directions.

The packing is rolled or folded to fit into the affected nostril. Once inserted, pressure is applied and the bleeding should stop quickly. The new product is available online at www.quikclot.com where the Manufacturer's Suggested Retail Price (MSRP) for a box of five sterile applications is $11.49.

QuikClot® NoseBleed™ brand is manufactured by Z-Medica Corporation, a medical products company focused on innovative hemostatic nano-technologies. The company manufactures and markets several other life-saving products for use by its original markets -- the military, first responders, industrial first aid teams and law enforcement personnel. In addition to this new generation consumer product, the company also now offers online at www.quikclot.com other consumer products that stop bleeding for home, travel, sport and pet use. Z-Medica Corp headquarters is located at 4 Fairfield Blvd., Wallingford, Connecticut 06492. For more information, please call (203) 294-0000 or visit www.z-medica.com.

# # #

Simillar Articles

Z-Medica Awarded $2.9 Million US Navy/Marine Corp Contract for Penetrating Wound Study Using its...

Five major university & hospital trauma centers will use QuikClot® Combat Gauze™ in clinical trials to study new methods for stopping bleeding in small entry/large exit wounds. This new...

TraumaCure Receives Health Canada Licensure for New Hemostatic Agent That Stops Major Bleeding in...

TraumaCure Inc. today announced that Health Canada has issued a medical device license for WoundStat™, a ground-breaking hemostatic agent for control of bleeding in high-pressure arterial...

TraumaCure Receives CE Mark Clearance to Sell WoundStat in Europe

TraumaCure Inc. announced today that its ground-breaking hemostatic agent, WoundStat™, has received CE Mark approval, clearing the way for sales in the European Union and all countries...

WoundStat Inventors Recognized for Their Outstanding Medical Research Contributions to Combat...

Virginia Commonwealth University (VCU) researchers Kevin Ward, MD, Robert Diegelmann, PhD, and Gary Bowlin, PhD, this week received the Award for Excellence in recognition of their outstanding...

ComforTrac to Feature Cervical and Lumbar Traction Devices at MEDICA

ComforTrac to Exhibit at MEDICA, Hall 4 booth F58. Manufacturer of home traction devices continues to experience strong international demand.

Home